✦ LIBER ✦

Consequences of chronic hepatitis C: A review article for the hematologist

✍ Scribed by Dr. Louis M. Aledort

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 901 KB
Volume: 44
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830440107

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The hepatitis C virus (HCV) has been cloned, and assays capable of detecting antibody to HCV recombinant proteins (anti‐HCV) have been developed. Concurrent with the cloning and development of the anti‐HCV screening tests, trials with interferon alfa‐2b have documented biochemical and histologic improvement in the indices of hepatitis C and non‐A, non‐B (NANB) in patients who were chronically infected. Subsequently, the anti‐HCV assays and interferon alfa‐2b have become clinically available. These new detection and treatment modalities can now be used in the management of hemophilics and other chronically transfused patients who bear great risk for blood‐borne infections and manifest signs of chronic hepatitis. © 1993 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

A pilot study of recombinant interleukin

A pilot study of recombinant interleukin-2 for treatment of chronic hepatitis C

✍ M Pardo; I Castillo; H Oliva; A Fernandez-Flores; R Barcena; M A de Peuter; V Ca 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 1 views

The optimal and safer interleukin-2 (IL-2) dose for treatment of chronic hepatitis C virus (HCV) infection has been studied in 33 HCV-RNA positive patients with chronic hepatitis C. Patients were randomly allocated to receive 5 days per week during 12 weeks IL-2 doses of: 0.9 MIU (n = 10), 1.8 MIU (

Chronic hepatitis C: The beginning of th

Chronic hepatitis C: The beginning of the end of a time-honored nomenclature?

✍ Michael A. Gerber 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB 👁 1 views

Limitations of the algorithm for the SAF

Limitations of the algorithm for the SAFE biopsy: A noninvasive fibrosis measure in chronic hepatitis C

✍ Mohammed Rashid; Jonathon D. Mitchell; Matthew E. Cramp; Timothy J. S. Cross 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 2 views

Infection of B cells with hepatitis C vi

Infection of B cells with hepatitis C virus for the development of lymphoproliferative disorders in patients with chronic hepatitis C

✍ Momoko Inokuchi; Takayoshi Ito; Manabu Uchikoshi; Yuu Shimozuma; Kenichi Morikaw 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 1 views

## Abstract Infection with hepatitis C virus (HCV) is associated with lymphoproliferative disorders, represented by essential mixed cryoglobulinemia and B‐cell non‐Hodgkin's lymphoma, but the pathogenic mechanism remains obscure. HCV may infect B cells or interact with their cell surface receptors,

The natural course of chronic hepatitis

The natural course of chronic hepatitis C: A comparison between patients with genotypes 1 and 2 hepatitis C viruses

✍ M Kobayashi; E Tanaka; T Sodeyama; A Urushihara; A Matsumoto; K Kiyosawa 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB

Methodological approaches in the assessm

Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C – a critical review

✍ Arne Schäfer; Hans-Ulrich Wittchen; Jochen Seufert; Michael R. Kraus 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 300 KB 👁 1 views

## Abstract In recent years, research on interferon (IFN)‐induced depressive symptoms in antivirally treated patients suffering from chronic hepatitis C (CHC) has considerably intensified. Profound scientific knowledge of this complication is of great relevance with regard to adherence, compliance,